Developing a New Scale for Evaluating Shoulder Problems
Launched by SULEYMAN DEMIREL UNIVERSITY · May 20, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on developing a new scale to better evaluate shoulder problems, such as injuries and pain. Currently, there are various ways to assess these issues, but many of them rely on self-reports using different scales. The goal of this study is to create a straightforward scale that asks clear yes or no questions about shoulder-related activities, making it easier for patients to understand and use. This new scale aims to improve how we measure shoulder problems and will be culturally adapted for use in Turkey.
To participate in the trial, you need to be between 18 and 80 years old, be able to read and write, and have shoulder-related issues. If you decide to join, you can expect to help in the development of a tool that could make it easier for others to describe their shoulder problems in the future. Your contributions could help improve treatment and support for people facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • literate
- • 18-80 years old
- • who volunteered to participate in the study
- • patients with shoulder problems
- Exclusion Criteria:
- • illiterate
- • not willing to participate.
About Suleyman Demirel University
Suleyman Demirel University is a prominent educational and research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the university collaborates with healthcare professionals and researchers to explore new therapeutic approaches and enhance patient care. Its clinical trial initiatives focus on a range of medical fields, aiming to contribute valuable insights to the scientific community and foster the development of effective treatment strategies. By prioritizing ethical standards and rigorous methodologies, Suleyman Demirel University plays a pivotal role in shaping the future of healthcare through evidence-based research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Isparta, , Turkey
Patients applied
Trial Officials
Ertuğrul Demirdel
Study Director
Ankara Yildirim Beyazıt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials